News
Advertisement
Advertisement
Advertisement
Lisa Henderson's recap on Wall Street's view on the CRO industry.
Live update from the IIR conference.
INFORMATION TECHNOLOGY : Revolution in Randomization Clinical Database: Proper Coding and Design Also in this issue : PDUFA Renewal, EFGCP Meeting on Informed Consent, Drug Development Cycle Time, Choosing an eClinical Solution
The FDA issued guidances in February that outlines its recommendations for developing and approving biosimilar therapies.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Extending Trial Registries for an AI-Driven Era of Patient Discovery
4
ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
5